Leading international law firm Herbert Smith Freehills has advised Bioniq, a global leader in AI-driven personalised vitamins and health-tech solutions, on its Series B funding round, a capital raise which sees Bioniq rocketing from strength to strength.
The Herbert Smith Freehills team was led by Dubai Partner Danila Logofet, supported by a team in London comprising partner David D’Souza, senior associate Matthew Gallagher and associate Joshua Avis.
Partner Danila Logofet said: ‘It has been a privilege to assist Bioniq and its founder in this exciting stage in the company’s journey. The funding round has strategically positioned the company to embark upon its next stage of growth and to consolidate upon the back of its success to date. By assisting this leading business in what is proving to be an exciting and dynamic time for the industry, we have displayed our strength in the AI and health-tech sectors, as well as the depth and reach of our international network.’
